HSBC Holdings Portfolio holdings
HSBC Holdings plc, founded in 1865 as the Hongkong and Shanghai Banking Corporation by Sir Thomas Sutherland to finance trade in East Asia, is a British multinational bank headquartered in London, managing trillions in assets as one of the world’s largest banking and financial services organizations. Operating in over 60 countries with a strong emphasis on Asia—where it generates much of its revenue—HSBC offers retail banking, wealth management, commercial banking, and global markets services to more than 40 million customers, supported by around 214,000 employees as of late 2024. Known for its international network and resilience through crises like the 1997 Asian financial downturn, HSBC has pivoted under Group CEO Noel Quinn (since 2020) to accelerate digital transformation and sustainability goals, targeting net-zero emissions by 2050. Despite challenges like geopolitical tensions and regulatory pressures, HSBC remains a cornerstone of global finance, leveraging its heritage as a trade financier into a modern, Asia-centric banking powerhouse.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$313M |
| 2 |
Advanced Micro Devices
AMD
|
+$209M |
| 3 |
TSMC
TSM
|
+$168M |
| 4 |
ATVI
Activision Blizzard
ATVI
|
+$160M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$139M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$6.82B |
| 2 |
Amazon
AMZN
|
+$643M |
| 3 |
Apple
AAPL
|
+$535M |
| 4 |
Procter & Gamble
PG
|
+$463M |
| 5 |
AstraZeneca
AZN
|
+$414M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.67% |
| 2 | Consumer Discretionary | 11.99% |
| 3 | Financials | 11.42% |
| 4 | Healthcare | 10.42% |
| 5 | Communication Services | 7.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ACB
3076
Aurora Cannabis
ACB
$173M
| $133K | ﹤0.01% |
3,379
+25
| +0.7% | +$1.06K |
|
3077
Diana Shipping
DSX
$302M
| $133K | ﹤0.01% |
+30,838
| New | +$108K |
|
3078
FuboTV Inc
FUBO
$261M
| $133K | ﹤0.01% |
1,638
+779
| +91% | +$90.9K |
|
3079
IDEAYA Biosciences
IDYA
$3.42B
| $133K | ﹤0.01% |
+11,787
| New | +$174K |
|
|
GOCO
3080
DELISTED
GoHealth
GOCO
| $132K | ﹤0.01% |
7,344
+1,622
| +28% | +$50.5K |
|
|
MFA
3081
MFA Financial
MFA
$926M
| $132K | ﹤0.01% |
8,209
+64
| +0.8% | +$1.11K |
|
|
CLVS
3082
DELISTED
Clovis Oncology, Inc.
CLVS
| $132K | ﹤0.01% |
+51,942
| New | +$102K |
|
3083
American Coastal Insurance
ACIC
$515M
| $130K | ﹤0.01% |
39,051
| – | – |
|
3084
Culp Inc
CULP
$44.1M
| $128K | ﹤0.01% |
16,166
| – | – |
|
3085
Remitly
RELY
$4.79B
| $128K | ﹤0.01% |
+12,811
| New | +$153K |
|
|
CELL
3086
DELISTED
PhenomeX Inc. Common Stock
CELL
| $126K | ﹤0.01% |
17,665
+5,939
| +51% | +$49.1K |
|
3087
Citizens
CIA
$239M
| $124K | ﹤0.01% |
29,037
| – | – |
|
3088
Banco Bilbao Vizcaya Argentaria
BBVA
$154B
| $123K | ﹤0.01% |
21,689
-865
| -4% | -$5.3K |
|
3089
CALL
Phillips 66
PSX
$84.9B
| $123K | ﹤0.01% |
+1,400
| New | +$118K |
|
3090
Mustang Bio
MBIO
$4.32M
| $122K | ﹤0.01% |
161
| – | – |
|
|
CNVY
3091
DELISTED
Convey Health Solutions Holdings, Inc.
CNVY
| $122K | ﹤0.01% |
+18,493
| New | +$122K |
|
3092
Organogenesis Holdings
ORGO
$305M
| $121K | ﹤0.01% |
+15,637
| New | +$121K |
|
3093
Nektar Therapeutics
NKTR
$2.39B
| $119K | ﹤0.01% |
1,460
+355
| +32% | +$52.5K |
|
3094
Axogen
AXGN
$2.27B
| $117K | ﹤0.01% |
+14,392
| New | +$124K |
|
3095
Ezcorp Inc
EZPW
$1.83B
| $117K | ﹤0.01% |
19,507
+6,042
| +45% | +$37.7K |
|
|
CTEV
3096
Claritev Corp
CTEV
$387M
| $117K | ﹤0.01% |
631
-321
| -34% | -$52.9K |
|
|
FMTX
3097
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
| $116K | ﹤0.01% |
+12,371
| New | +$132K |
|
|
CRON
3098
Cronos Group
CRON
$1.06B
| $115K | ﹤0.01% |
29,395
-18,165
| -38% | -$66.2K |
|
|
PTRA
3099
DELISTED
Proterra Inc. Common Stock
PTRA
| $115K | ﹤0.01% |
15,315
+444
| +3% | +$3.6K |
|
3100
Array Technologies
ARRY
$803M
| $114K | ﹤0.01% |
+10,095
| New | +$113K |
|
Similar funds
HSBC Holdings's Q1 2022 Portfolio in Review
As of Q1 2022, HSBC Holdings held 3,586 positions worth $82.3B, down 24% from $108B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
HSBC Holdings withdrew a net $19.7B in Q1 2022, closing 339 positions and reducing 1,273 holdings. Its most notable exit was Xilinx Inc, an estimated $127M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, HSBC Holdings opened a new position in iShares Global Energy ETF worth $110M.
- HSBC Holdings's largest Q1 2022 buy was iShares Global Energy ETF: 3,037,936 shares worth $110M.
- HSBC Holdings added most to Meta Platforms (Facebook) in Q1 2022, an estimated $313M increase.
- HSBC Holdings's biggest Q1 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $6.82B.
- HSBC Holdings fully exited Xilinx Inc in Q1 2022, selling an estimated $127M.
- HSBC Holdings's ten largest holdings make up 25% of its $82.3B portfolio in Q1 2022.
- HSBC Holdings opened 347 new positions and closed 339 in Q1 2022.
- HSBC Holdings's portfolio value fell 24% quarter-over-quarter to $82.3B.
Based on HSBC Holdings's 13F filing for Q1 2022, filed 16 May 2022.